QT Sense, a deep-tech biotech startup, has announced that it has secured €4 million in funding to advance its Quantum Nuova platform, a technology designed to study living cells and observe cellular processes in real time.
The funding includes a €3 million seed investment led by Cottonwood Technology Fund, with follow-on backing from existing investor QDNL Participations and an angel investor. Additionally, QT Sense received €600,000 from the ONCO-Q programme to support cancer research and €400,000 through the Quantum Forward Challenge for collaborative deployments with research partners. This investment will help accelerate the development of the Quantum Nuova platform, which aims to reveal biochemical activity linked to disease.
The funding is expected to have a significant impact on the company’s ability to advance its research and development. With the support of its investors and partners, QT Sense is poised to make significant strides in the field of biotech research. The company’s technology has the potential to revolutionize the way scientists study living cells and understand disease, and the funding will help bring this technology to the forefront of the research community.
Leave a Reply